ACE gene polymorphism and diabetic complications: is there a connection?

No abstract is available for this paper.

• Publication year

  2000

• Venue

  BioDrugs

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 18034559
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of balloon angioplasty on high grade symptomatic vasospasm after subarachnoid hemorrhage

  2004cited by this paper
• The I/D Polymorphism of Angiotensin-Converting Enzyme Gene but not the Angiotensinogen Gene is Associated with Insulin Response to Oral Glucose in Japanese

  1999cited by this paper
• BAD GENES, GOOD PEOPLE, ASSOCIATION, LINKAGE, LONGEVITY AND THE PREVENTION OF CARDIOVASCULAR DISEASE

  1999cited by this paper
• Contribution of bradykinin to the beneficial effects of ramipril in the fructose-fed rat.

  1998cited by this paper
• Receptors and their classification: focus on angiotensin II and the AT2 receptor

  1998cited by this paper
• Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy

  1998cited by this paper
• Effects of angiotensin II on endothelial cell growth: role of AT-1 and AT-2 receptors.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Role of bradykinin in the reduction of left ventricular hypertrophy induced by angiotensin-converting enzyme inhibitors in spontaneously hypertensive rats.

  1998cited by this paper
• Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM.

  1998cited by this paper
• Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.

  1998cited by this paper
• Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.

  1998cited by this paper
• Angiotensin II inhibits growth of cultured embryonic renomedullary interstitial cells through the AT2 receptor.

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity.

  1997cited by this paper
• ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients.

  1997cited by this paper
• Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control

  1997cited by this paper
• Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.

  1997cited by this paper
• Contribution of bradykinin to the cardioprotective action of angiotensin converting enzyme inhibition in hypertension and after myocardial infarction.

  1997cited by this paper
• The insertion allele at the angiotensin I-converting enzyme gene locus is associated with insulin resistance.

  1997cited by this paper
• Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension

  1997cited by this paper
• The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular‐renal risk

  1997cited by this paper
• Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes.

  1997cited by this paper
• Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy.

  1997cited by this paper
• Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics.

  1996cited by this paper
• Aortic atherosclerosis in diabetes mellitus is associated with an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene

  1996cited by this paper
• Polymorphisms of the renin-angiotensin system genes in progressive renal diseases.

  1996cited by this paper
• Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus.

  1996cited by this paper
• Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM

  1996cited by this paper
• Is ACE Gene Polymorphism a Useful Marker for Diabetic Albuminuria in Japanese NIDDM Patients?

  1996cited by this paper
• Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study

  1996cited by this paper
• Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients.

  1996cited by this paper
• Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy.

  1996cited by this paper
• Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM

  1996cited by this paper
• Lack of Relationship Between an Insertion/Deletion Polymorphism in the Angiotensin I–Converting Enzyme Gene and Diabetic Nephropathy and Proliferative Retinopathy in IDDM Patients

  1995cited by this paper
• Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group.

  1995cited by this paper
• Angiotensin Converting Enzyme (ACE) Insertion/Deletion (I/D) Polymorphism, and Diabetic Retinopathy in Subjects with IDDM and NIDDM

  1995cited by this paper
• UK Prospective Diabetes Study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM

  1995cited by this paper
• Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme.

  1995cited by this paper
• Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.

  1995cited by this paper
• U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM.

  1995cited by this paper
• In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer.

  1995cited by this paper
• Angiotensin I-Converting Enzyme Gene Polymorphism Is Associated With Myocardial Infarction, but Not With Retinopathy or Nephropathy, in NIDDM

  1995cited by this paper
• The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance?

  1995cited by this paper
• Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia.

  1995cited by this paper
• Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications.

  1994cited by this paper
• Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus.

  1994cited by this paper
• Genetic associations with human longevity at the APOE and ACE loci

  1994cited by this paper
• Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes.

  1993cited by this paper
• Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.

  1992cited by this paper
• Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

  1992cited by this paper
• Risk factors for renal and cardiovascular disease in diabetic patients.

  1991cited by this paper
• The angiotensin II receptor and the actions of angiotensin II.

  1990cited by this paper
• Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus

  1990cited by this paper
• An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

  1990cited by this paper
• A FOS protein is present in a complex that binds a negative regulator of MYC.

  1989cited by this paper
• Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.

  1989cited by this paper

• Immunopathology of sarcoidosis.

  2014cites this paper
• The ocular renin-angiotensin system: a therapeutic target for the treatment of ocular disease.

  2014cites this paper
• Plasma level of interferon γ induced protein 10 is a marker of sarcoidosis disease activity.

  2013cites this paper
• Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas.

  2008cites this paper
• Expression of the monocarboxylate transporter MCT1 in the adult human brain cortex.

  2006cites this paper
• Cortical layer-dependent BOLD and CBV responses measured by spin-echo and gradient-echo fMRI: Insights into hemodynamic regulation

  2006cites this paper
• Frontal cortical areas of the monkey brain engaged in reaching behavior: A 14C-deoxyglucose imaging study

  2005cites this paper
• High intensity exercise decreases global brain glucose uptake in humans

  2005cites this paper
• Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons

  2003cites this paper